Virginia Barbour
Virginia Barbour
Verified email at Qut.edu.au
Title
Cited by
Cited by
Year
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
KF Schulz, DG Altman, D Moher
Trials 11 (1), 1-8, 2010
114382010
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials
D Moher, S Hopewell, KF Schulz, V Montori, PC Gøtzsche, PJ Devereaux, ...
Journal of clinical epidemiology 63 (8), e1-e37, 2010
75762010
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ...
Bmj 348, 2014
37952014
Reprint—preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
D Moher, A Liberati, J Tetzlaff, DG Altman, Prisma Group
Physical therapy 89 (9), 873-880, 2009
14752009
CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration
S Hopewell, M Clarke, D Moher, E Wager, P Middleton, DG Altman, ...
PLoS Med 5 (1), e20, 2008
5582008
Potential predatory and legitimate biomedical journals: can you tell the difference? A cross-sectional comparison
L Shamseer, D Moher, O Maduekwe, L Turner, V Barbour, R Burch, ...
BMC medicine 15 (1), 1-14, 2017
2382017
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
D Mother, A Liberati, J Tetzlaff, D Altman
PLoS Med 6 (7), e1000097, 2009
1622009
Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration
V Welch, M Petticrew, J Petkovic, D Moher, E Waters, H White, P Tugwell, ...
Journal of clinical epidemiology 70, 68-89, 2016
1342016
UK Biobank: a project in search of a protocol?
V Barbour
The Lancet 361 (9370), 1734-1738, 2003
1102003
Retractions: guidance from the Committee on Publication Ethics (COPE)
E Wager, V Barbour, S Yentis, S Kleinert
Maturitas 64 (4), 201-203, 2009
872009
Nephrotic syndrome associated with sulphasalazine.
VM Barbour, PF Williams
BMJ: British Medical Journal 301 (6755), 818, 1990
701990
The Hong Kong Principles for assessing researchers: Fostering research integrity
D Moher, L Bouter, S Kleinert, P Glasziou, MH Sham, V Barbour, ...
PLoS Biology 18 (7), e3000737, 2020
612020
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ...
Gesundheitswesen (Bundesverband der Arzte des Offentlichen …, 2016
56*2016
α-Thalassemia resulting from a negative chromosomal position effect
VM Barbour, C Tufarelli, JA Sharpe, ZE Smith, H Ayyub, CA Heinlein, ...
Blood, The Journal of the American Society of Hematology 96 (3), 800-807, 2000
472000
Optimal evidence in difficult settings: improving health interventions and decision making in disasters
M Gerdin, M Clarke, C Allen, B Kayabu, W Summerskill, D Devane, ...
PLoS Med 11 (4), e1001632, 2014
462014
How ghost-writing threatens the credibility of medical knowledge and medical journals
V Barbour
haematologica 95 (1), 1, 2010
432010
Targeted disruption of the CP2 gene, a member of the NTF family of transcription factors
L Ramamurthy, V Barbour, A Tuckfield, DR Clouston, D Topham, ...
Journal of Biological Chemistry 276 (11), 7836-7842, 2001
392001
Ten simple rules for building and maintaining a scientific reputation
PE Bourne, V Barbour
PLoS comput biol 7 (6), e1002108, 2011
372011
Core competencies for scientific editors of biomedical journals: consensus statement
D Moher, J Galipeau, S Alam, V Barbour, K Bartolomeos, P Baskin, ...
BMC medicine 15 (1), 1-10, 2017
342017
Defective extraembryonic angiogenesis in mice lacking LBP-1a, a member of the grainyhead family of transcription factors
V Parekh, A McEwen, V Barbour, Y Takahashi, JE Rehg, SM Jane, ...
Molecular and cellular biology 24 (16), 7113-7129, 2004
342004
The system can't perform the operation now. Try again later.
Articles 1–20